Asia Pacific GMP testing service market will grow by 9.0% annually with a total addressable market cap of $16,847.8 million over 2022-2031, driven by the growing pharmaceutical industry and the increasing need for developing novel drugs and medical devices, the rising outsourcing activities for quality assurance, and the fast-growing cosmetics industry and food & beverage industry. Highlighted with 27 tables and 38 figures, this 91-page report “Asia Pacific GMP Testing Service Market 2...
Global Hemodynamic Monitoring Systems Market will reach $ 2,082.0 million by 2031, growing by 6.7% annually over 2021-2031, driven by the rising prevalence of cardiovascular diseases & diabetes, increasing geriatric population, the introduction of more innovative and non-invasive devices, extensive research and development (R&D) activities, and the increasing healthcare concerns and expenditure amid COVID-19 pandemic. Highlighted with 81 tables and 74 figures, this 162-page report “Glob...
North America hemodynamic monitoring systems market is projected to grow by 6.3% annually in the forecast period and reach $ 826.1 million by 2031, driven by the rising prevalence of cardiovascular diseases & diabetes, increasing geriatric population, the introduction of more innovative and non-invasive devices, extensive research and development (R&D) activities, and the increasing healthcare concerns and expenditure amid COVID-19 pandemic. Highlighted with 21 tables and 38 figures, thi...
Europe hemodynamic monitoring systems market was valued at $287.9 million in 2021 and will grow by 5.9% annually over 2021-2031, driven by the rising prevalence of cardiovascular diseases & diabetes, increasing geriatric population, the introduction of more innovative and non-invasive devices, extensive research and development (R&D) activities, and the increasing healthcare concerns and expenditure amid COVID-19 pandemic. Highlighted with 31 tables and 42 figures, this 107-page report â...
Asia Pacific hemodynamic monitoring systems market will grow by 8.0% annually with a total addressable market cap of $4,242.7 million over 2022-2031, driven by the rising prevalence of cardiovascular diseases & diabetes, increasing geriatric population, the introduction of more innovative and non-invasive devices, extensive research and development (R&D) activities, and the increasing healthcare concerns and expenditure amid COVID-19 pandemic. Highlighted with 28 tables and 41 figures, t...
Global pharmaceutical contract research organization (CRO) market will reach $45.0 billion by 2030, growing by 9.8% annually over 2021-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Highlighted with 118 tables and 80 figures, this 194-page report “Global Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Ap...
North America pharmaceutical contract research organization (CRO) market is projected to grow by 9.0% annually in the forecast period and reach $37.61 billion by 2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Highlighted with 59 tables and 44 figures, this 132-page report “North America Pharmaceutical Contract Research Organization (CRO) Market 202...
Europe pharmaceutical contract research organization (CRO) market was valued at $12.13 billion in 2021 and will grow by 9.6% annually over 2021-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Highlighted with 69 tables and 48 figures, this 140-page report “Europe Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therap...
Asia Pacific pharmaceutical contract research organization (CRO) market will grow by 11.3% annually with a total addressable market cap of $ 212.8 billion over 2022-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Highlighted with 66 tables and 47 figures, this 139-page report “Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2...
Global digital PCR (dPCR) market will reach $ 1,169.9 million by 2031, growing by 11.8% annually over 2021-2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities. Highlighted with 83 tables and 77 figures, this 157-page report “Global Digital PCR (dPCR) Market 2021-2031 by Offering (Instruments & Accessories, R...
